In fact, treatment of GPx2 KD tumor-bearing mice with echinomycin, a drug that inhibits HIF1α (29), reduced VEGFA expression and tumor growth, while improving vessel maturation (48), underscoring the effect of GPx2 loss on vascular malfunction. Here, GPX2 is linked to neoplasm.